BRIAN PULLAM: Open Payments
NPI 1770121535 · NICEVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 30 payments from 12 companies in 2025. Trend: 2023 $1,651 · 2024 $391 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Lundbeck LLC | 3 | $64 |
| Corium, LLC | 2 | $62 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $32 |
| ABBVIE INC. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Exelixis Inc. | 1 | $20 |
Products named: REXULTI, CAPLYTA, Azstarys, Auvelity, FANAPT, Quviviq, VENCLEXTA, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
